Epigenes that participate in the immune response through different mechanisms (response to interferon or NF-kB complex) are among the main genes identified and are evident drug target candidates for COVID-19 because they already have associated drugs targeting them (such as STAT5A and STAT1). The gene discussed is STAT5A; the disease is COVID-19.